NFKB1 and cancer: Remarkably, within the tumor microenvironment, TNF-α increase activates NF-kB in cancer cells, leading to the further increase of deubiquitinase CSN5 (COP9 signalosome 5) expression which inhibits PD-L1 degradation, facilitating immune escape of cancer cells.